Name: Retatrutide+Cagrilintide Compound Peptide

Synonyms: Triple Receptor Agonist Blend, Multi-Target Weight Management Peptide Mixed CAS Registry number: Retatrutide 2757842-85-6, Cagrilintide 1415456-99-3

99% Pharmaceutical-Grade Purity - Rigorously compounded lyophilized peptide for synergistic appetite suppression, fat reduction and blood glucose regulation laboratory research use. 1.Lab-Verified Fixed Ratio Vials - Precisely blended sterile lyophilized powder with 5mg Retatrutide+5mg Cagrilintide for laboratory and research applications. 2.Metabolic Synergy Benefits: Retatrutide acts as GLP-1/GIP/GCGR triple agonist to lower blood sugar and burn fat; Cagrilintide is amylin analog to prolong satiety and slow stomach emptying. Combined formula produces stronger metabolic regulation effects for obesity, type 2 diabetes and metabolic disorder research studies. 3.Third-Party HPLC/LC-MS Tested - Each batch passes strict purity and identity testing with complete COA documentation. 4.Easy Reconstitution - Quickly dissolved with bacteriostatic water for convenient laboratory research use.